You are here

2017 VAM: One for the Record Books

The 2017 Vascular Annual Meeting is now part of SVS history – and it made history, as well.

A shattered attendance record. Heavily attended symposia breakfast sessions. A packed house for the Presidential Address and introduction. A record number of participating organizations for the Residency Fair. And more collaborative sessions than ever before.

Attendees were exposed to hundreds of abstracts; more than a dozen concurrent sessions, including seven joint sessions with specialty societies; six postgraduate courses; eight plenary sessions; and receptions galore. Participants came from nearly every state, the District of Columbia and more than 35 countries.

The common bond: the desire to learn more about vascular disease – new treatments, the latest innovations and research – and improve patient care.

The 2017 meeting, held in San Diego, attracted the most attendees ever – 1,807 – and set another record for international attendance, with 362 registrations, 20 percent of the professional total. The bay sparkled, the speakers were thought-provoking, and the education was first-rate.

The event could not have gone better, said SVS President Dr. R. Clement Darling III. "Over and over I heard nothing but great feedback," he said.

"I would like to extend our congratulations and thanks to all the hardworking member volunteers who helped to make this event a success. And none of that would be possible without the generosity of our sponsors."

VAM sponsors were: Abbot; Acelity; Bard Peripheral Vascular, Inc.; BTG; Cook Medical; CryoLife, Inc.; Getinge; Gore; and Metronic.

Educational grants were provided by: Abbott; Boston Scientific Corporation; Cordis®, A Cardinal Health company; Endologix, Inc.; Gore; and Medtronic.